$SIGA
SIGA TECHNOLOGIES INC Stock $siga

$siga Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000101008619000011 Filed on May 02, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$10.46M	$1.748M
YoY Change	498.34%	-66.4%
Cost Of Revenue	$915.0K	$0.00
YoY Change
Gross Profit	$9.544M	$1.748M
YoY Change	446.0%
Gross Profit Margin	91.25%	100.0%
Selling, General & Admin	$3.167M	$3.057M
YoY Change	3.58%	6.52%
% of Gross Profit	33.18%	174.89%
Research & Development	$3.997M	$3.008M
YoY Change	32.89%	-52.7%
% of Gross Profit	41.88%	172.08%
Depreciation & Amortization	$137.7K	$29.79K
YoY Change	362.32%	-17.25%
% of Gross Profit	1.44%	1.7%
Operating Expenses	$8.267M	$6.283M
YoY Change	31.58%	-33.66%
Operating Profit	$2.192M	-$4.535M
YoY Change	-148.33%	6.23%
Interest Expense	$3.928M	$3.749M
YoY Change	4.79%	3.88%
% of Operating Profit	179.22%
Other Income/Expense, Net	$736.1K	$2.235K
YoY Change	32836.42%	-49.42%
Pretax Income	$2.136M	-$11.58M
YoY Change	-118.44%	-236.29%
Income Tax	$506.2K	-$2.352K
% Of Pretax Income	23.7%
Net Earnings	$1.630M	-$11.58M
YoY Change	-114.07%	34.44%
Net Earnings / Revenue	15.58%	-662.59%
Basic Earnings Per Share	$0.02	-$0.15
Diluted Earnings Per Share	-$0.02	-$0.15
COMMON SHARES
Basic Shares Outstanding	80.91M	79.04M shares
Diluted Shares Outstanding	82.14M	79.04M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$102.1M	$13.90M
YoY Change	634.53%	-53.82%
Cash & Equivalents	$102.1M	$13.93M
Short-Term Investments
Other Short-Term Assets	$15.40M	$12.80M
YoY Change	20.31%	16.36%
Inventory	$2.017M	$2.983M
Prepaid Expenses
Receivables	$4.100M	$1.264M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$123.5M	$30.93M
YoY Change	299.38%	-52.54%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.987M	$108.9K
YoY Change	2644.54%	-58.66%
Goodwill	$898.3K	$898.3K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$993.0K	$702.2K
YoY Change	41.41%	9.36%
Total Long-Term Assets	$82.90M	$102.2M
YoY Change	-18.89%	6.85%
TOTAL ASSETS
Total Short-Term Assets	$123.5M	$30.93M
Total Long-Term Assets	$82.90M	$102.2M
Total Assets	$206.4M	$133.1M
YoY Change	55.06%	-17.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.150M	$432.2K
YoY Change	397.36%	-80.87%
Accrued Expenses	$9.958M	$3.586M
YoY Change	177.67%	21.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.11M	$4.018M
YoY Change	201.3%	-68.01%
LONG-TERM LIABILITIES
Long-Term Debt	$76.70M	$72.20M
YoY Change	6.23%	6.65%
Other Long-Term Liabilities	$11.60M	$391.6M
YoY Change	-97.04%	4.04%
Total Long-Term Liabilities	$88.30M	$463.8M
YoY Change	-80.96%	4.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.11M	$4.018M
Total Long-Term Liabilities	$88.30M	$463.8M
Total Liabilities	$100.4M	$467.8M
YoY Change	-78.54%	2.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$114.2M	$200.0K
YoY Change	-57180.74%	-100.04%
Common Stock	$220.2M	$214.6M
YoY Change	2.64%	0.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$106.1M	-$334.6M
YoY Change
Total Liabilities & Shareholders Equity	$206.4M	$133.1M
YoY Change	55.06%	-17.21%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$1.630M	-$11.58M
YoY Change	-114.07%	34.44%
Depreciation, Depletion And Amortization	$137.7K	$29.79K
YoY Change	362.32%	-17.25%
Cash From Operating Activities	$9.379K	-$8.562M
YoY Change	-100.11%	817.68%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change
Cash From Investing Activities	-$8.951K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-56.59K	$0.00
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	9.379K	-$8.562M
Cash From Investing Activities	-8.951K	$0.00
Cash From Financing Activities	-56.59K	$0.00
Net Change In Cash	-56.16K	-$8.562M
YoY Change	-99.34%	660.35%
FREE CASH FLOW
Cash From Operating Activities	$9.379K	-$8.562M
Capital Expenditures	-$10.00K
Free Cash Flow	$19.38K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	14400000	USD
CY2018Q3	siga	Contract Value Detail Of Option Exercisable Production Activities ContractValueDetailOfOptionExercisableProductionActivities	536200000	USD
CY2019Q1	siga	Contract Value Option Fda Approval ContractValueOptionFDAApproval	50000000	USD
CY2011Q2	siga	Contract Valueof Various Options ContractValueofVariousOptions	72700000	USD
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001010086
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80941524	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	SIGA TECHNOLOGIES INC
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q1	dei	Trading Symbol TradingSymbol	SIGAQ
CY2018Q4	siga	Accrued Researchand Development Vendor Costs Current AccruedResearchandDevelopmentVendorCostsCurrent	1446410	USD
CY2019Q1	siga	Accrued Researchand Development Vendor Costs Current AccruedResearchandDevelopmentVendorCostsCurrent	628565	USD
CY2019Q1	siga	Amount Received From Contractfor Developmentand Support Activities AmountReceivedFromContractforDevelopmentandSupportActivities	44300000	USD
CY2018Q4	siga	Computer Equipment Gross ComputerEquipmentGross	618248	USD
CY2019Q1	siga	Computer Equipment Gross ComputerEquipmentGross	581654	USD
CY2011Q2	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	58300000	USD
CY2019Q1	siga	Contract Value Detail Of Option Exercisable Development Activities ContractValueDetailOfOptionExercisableDevelopmentActivities	12200000	USD
CY2018Q1	siga	Conversionof Warrantsto Common Stock ConversionofWarrantstoCommonStock	0	USD
CY2019Q1	siga	Conversionof Warrantsto Common Stock ConversionofWarrantstoCommonStock	1172801	USD
CY2018Q1	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	-3300000	USD
CY2018Q1	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	-3303114	USD
CY2019Q1	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	3136265	USD
CY2019Q1	siga	Gain Lossfrom Changein Fair Valueof Warrant GainLossfromChangeinFairValueofWarrant	3100000	USD
CY2018Q3	siga	Government Contract Base Valueof Award For Deliveryof Courses GovernmentContractBaseValueofAwardForDeliveryofCourses	11100000	USD
CY2019Q1	siga	Government Contract Number Of Courses Purchased Under Modified Contract GovernmentContractNumberOfCoursesPurchasedUnderModifiedContract	1700000	contract
CY2011Q2	siga	Government Contract Numberof Additional Courses Purchased Under Modified Contract GovernmentContractNumberofAdditionalCoursesPurchasedUnderModifiedContract	300000	course
CY2019Q1	siga	Government Contract Numberof Paymentstobe Paid Upon Deliveryof Bulk Drug Substance GovernmentContractNumberofPaymentstobePaidUponDeliveryofBulkDrugSubstance	3200000	USD
CY2018Q3	siga	Government Contract Paymentsfor Supportive Procurement Activities GovernmentContractPaymentsforSupportiveProcurementActivities	600000	USD
CY2011Q2	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	508700000	USD
CY2018Q3	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	600100000	USD
CY2019Q1	siga	Government Contract Value Of Award1 GovernmentContractValueOfAward1	32000000	USD
CY2018Q3	siga	Number Of Courses To Be Delivered1 NumberOfCoursesToBeDelivered1	1488000	course
CY2018Q3	siga	Numberof Courses Delivered Options Final Drug Product NumberofCoursesDeliveredOptionsFinalDrugProduct	35700	course
CY2018Q3	siga	Governmentcontractbasevalueawardfordeliveryandsupportactivities Governmentcontractbasevalueawardfordeliveryandsupportactivities	51700000	USD
CY2018Q1	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	3303114	USD
CY2019Q1	siga	Increase In Fair Value Of Warrants IncreaseInFairValueOfWarrants	-3136265	USD
CY2019Q1	siga	Numberof Courses Options Final Drug Product NumberofCoursesOptionsFinalDrugProduct	20000	course
CY2019Q1	siga	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1172801	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1688488	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2149605	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1959133	USD
CY2018Q3	siga	Numberof Courses Storedas Vendor Managed Inventory NumberofCoursesStoredasVendorManagedInventory	212000	course
CY2019Q1	siga	Numberof Coursesthat Paymentwas Receivedfor NumberofCoursesthatPaymentwasReceivedfor	23000	course
CY2018Q3	siga	Numberof Primary Manufacturing Steps NumberofPrimaryManufacturingSteps	2	step
CY2019Q1	siga	Numberof Renewal Options NumberofRenewalOptions	2	option
CY2018Q3	siga	Numberofcoursesbasefinaldrugproduct Numberofcoursesbasefinaldrugproduct	8000000	USD
CY2018Q1	siga	Patent Preparation Fees PatentPreparationFees	218472	USD
CY2019Q1	siga	Patent Preparation Fees PatentPreparationFees	187916	USD
CY2019Q1	siga	Proceeds From Manufacture And Physical Delivery Of Courses Government Contracts ProceedsFromManufactureAndPhysicalDeliveryOfCoursesGovernmentContracts	459800000	USD
CY2019Q1	siga	Proceedsfor Deliveryof Courses ProceedsforDeliveryofCourses	7100000	USD
CY2018Q4	siga	Proceedsfrom Saleof Priority Review Voucher ProceedsfromSaleofPriorityReviewVoucher	78300000	USD
CY2019Q1	siga	Researchand Development Future Aggregate Amount ResearchandDevelopmentFutureAggregateAmount	5200000	USD
CY2018Q4	siga	Rightof Use Asset Gross RightofUseAssetGross	0	USD
CY2019Q1	siga	Rightof Use Asset Gross RightofUseAssetGross	2944932	USD
CY2018Q1	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	1108916	USD
CY2019Q1	siga	Stock Issuance Fees Expense StockIssuanceFeesExpense	1108916	USD
CY2019Q1	siga	Stock Issued During Period Value Stock Settled Appreciation Rights Exercised StockIssuedDuringPeriodValueStockSettledAppreciationRightsExercised	0	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4099954	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2600839	USD
CY2019Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	764059	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9648917	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9957736	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	242043	USD
CY2019Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	497276	USD
CY2018Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	294794	USD
CY2019Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	348167	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3244861	USD
CY2019Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3337041	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	218697872	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	220222959	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	327360	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	408894	USD
CY2018Q4	us-gaap	Assets Assets	203443741	USD
CY2019Q1	us-gaap	Assets Assets	206439348	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	121289845	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	123538666	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19857833	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13934807	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100652809	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	102085215	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37101586	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28539883	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180396910	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180340748	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-8561703	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-56162	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80941524	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80941524	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80763350	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80763350	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	8076	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	8094	USD
CY2019Q1	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	400000	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	915367	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-223313	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9758	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	505678	USD
CY2018Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4159946	USD
CY2019Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5437774	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	11733385	USD
CY2019Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	11227707	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29790	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	137724	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0002
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2370
CY2019Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3136265	USD
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	12380939	USD
CY2019Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8071873	USD
CY2018Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	377859	USD
CY2019Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	377859	USD
CY2018Q4	us-gaap	Goodwill Goodwill	898334	USD
CY2019Q1	us-gaap	Goodwill Goodwill	898334	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-11584608	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2135930	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2352	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	506153	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2792043	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-937637	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-645730	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2140821	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-184864	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	0	USD
CY2018Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	169269	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1277828	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	0	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-891133	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-65916	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-66122	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-244248	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-119433	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-442484	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1225788	shares
CY2018Q1	us-gaap	Interest Expense InterestExpense	3748818	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	3928418	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	35567	USD
CY2019Q1	us-gaap	Interest Payable Current InterestPayableCurrent	1003911	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	957765	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	68221	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	2908210	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	2017077	USD
CY2018Q4	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	1950445	USD
CY2019Q1	us-gaap	Inventory Work In Process And Raw Materials InventoryWorkInProcessAndRawMaterials	1948856	USD
CY2018Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2019Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2420028	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3787772	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1387139	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	402078	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	368467	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	600362	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	591108	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	438618	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	587491	USD
CY2018Q4	us-gaap	Liabilities Liabilities	100529054	USD
CY2019Q1	us-gaap	Liabilities Liabilities	100369779	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	203443741	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	206439348	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11337405	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12107341	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	75547597	USD
CY2019Q1	us-gaap	Long Term Debt LongTermDebt	76656511	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-56590	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8951	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8561703	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9379	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-11582256	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1629777	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-11582256	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1506488	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2235	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	736129	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	6282845	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	8267130	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4534911	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2191954	USD
CY2018Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	100000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	3200281	USD
CY2018Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	100000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0453
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y9M22D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3019928	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	541376	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	352000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	320774	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	304000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	304000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1197778	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	869318	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1277984	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1058880	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	992966	USD
CY2018Q4	us-gaap	Other Liabilities OtherLiabilities	1263113	USD
CY2019Q1	us-gaap	Other Liabilities OtherLiabilities	3534054	USD
CY2018Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	0	USD
CY2019Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	8951	USD
CY2019Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	87875	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	56590	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4317615	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3875130	USD
CY2019Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1172801	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3416135	USD
CY2019Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6324473	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	171274	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2987432	USD
CY2018Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	200000	USD
CY2019Q1	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	50000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3007827	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3997281	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11452078	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	11461290	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	68292023	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	66794243	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	10701305	USD
CY2018Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	10850136	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11452078	USD
CY2019Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	11461290	USD
CY2017Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6542448	USD
CY2018Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3754940	USD
CY2018Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	68292023	USD
CY2019Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	66794243	USD
CY2019Q1	us-gaap	Restructuring Charges RestructuringCharges	9189	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	509937	USD
CY2019Q1	us-gaap	Restructuring Reserve RestructuringReserve	431251	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-115791261	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-114161484	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1747934	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10459084	USD
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	60000000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3056546	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3166566	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	327360	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	408894	USD
CY2018Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2019Q1	us-gaap	Stock Issued1 StockIssued1	118500	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-323138291	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	-334616500	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	102914687	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	106069569	USD
CY2018Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	12380939	USD
CY2019Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	8071873	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79039000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82139108	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79039000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	80913320	shares

Files In Submission

Name	View Source	Status
0001010086-19-000011-index-headers.html	Edgar Link	pending
0001010086-19-000011-index.html	Edgar Link	pending
0001010086-19-000011.txt	Edgar Link	pending
0001010086-19-000011-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
siga-20190331.xml	Edgar Link	completed
siga-20190331.xsd	Edgar Link	pending
siga-20190331x10q.htm	Edgar Link	pending
siga-20190331_cal.xml	Edgar Link	unprocessable
siga-20190331_def.xml	Edgar Link	unprocessable
siga-20190331_lab.xml	Edgar Link	unprocessable
siga-20190331_pre.xml	Edgar Link	unprocessable
siga-exhibit3112019q1.htm	Edgar Link	pending
siga-exhibit3122019q1.htm	Edgar Link	pending
siga-exhibit3212019q1.htm	Edgar Link	pending
siga-exhibit3222019q1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SIGA
SIGA TECHNOLOGIES INC Stock $siga

2019 Q1 Form 10-Q Financial Statement

#000101008619000011 Filed on May 02, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA SIGA TECHNOLOGIES INC Stock $siga

2019 Q1 Form 10-Q Financial Statement

#000101008619000011 Filed on May 02, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SIGA
SIGA TECHNOLOGIES INC Stock $siga